• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Coagulation & Plasma Transfusion

Distinct Roles for Differently Aged Platelets

Platelets are derived from megakaryocytes in the bone marrow and have a lifespan of about seven to ten days in…

April 23, 2025

Prothrombin Complex Concentrate Is Safe and Effective for Cardiac Surgery Patients with Coagulopathic Bleeding

Around 15% of cardiac surgery patients experience excessive bleeding, often due to a depletion of coagulation factors. Up to 30%…

April 2, 2025

Plasma Transfusion Practices in ICUs Globally

Platelet transfusion guidelines discourage prophylactic plasma transfusion for non-bleeding patients, yet findings from the International Point Prevalence Study of Intensive…

February 18, 2025

RBCs Regulate Hemostasis Through Platelet-Dependent and -Independent Mechanisms

Red blood cells (RBCs) deliver oxygen to tissues and also contribute to hemostasis and thrombosis through platelet interactions that promote…

October 9, 2024

Recombinant ADAMTS13 Treatment for Congenital Thrombotic Thrombocytopenic Purpura

Congenital thrombotic thrombocytopenic purpura (TTP) is a rare disease caused by a severe hereditary deficiency of ADAMTS13, which normally cleaves…

May 15, 2024

Increasing Data Available for Plasma Transfusion Indications

Plasma transfusions are often used to prevent and/or treat bleeding and to control blood volume in patients with trauma or…

April 23, 2024

Safety of Platelet and Plasma Transfusions in the COVID-19 Era

By September 2022, 96% of U.S. blood donors had antibodies to SARS-CoV-2 due to infection and/or vaccination.  Some patient advocacy…

December 13, 2023

COVID-19 Convalescent Plasma Reduces Mortality for Patients with Acute Respiratory Distress Syndrome

COVID-19 mortality among patients in the intensive care unit receiving mechanical ventilation is around 45%, and little data exists on…

November 8, 2023

Recombinant von Willebrand Factor and Tranexamic Acid for Menstruating Women with von Willebrand Disease

Von Willebrand disease is an inherited bleeding disorder affecting about 0.1% of the population.  Von Willebrand disease is caused by…

September 13, 2023

Concizumab Lowers Rate of Bleeding in Hemophilia Patients with Inhibitors

While current guidelines for treating patients with hemophilia A or B recommend intravenous factor VIII or IX concentrates, many patients…

September 6, 2023

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 9
  • Go to Next Page »

Primary Sidebar

Latest News

  • Directed Blood Donations Should be Limited

  • Babesia Infection Reduces Red Cell Deformability

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley